Bora Pharmaceuticals Co Ltd(TW:6472)
NT$403.00+11.50 (+2.94%)
TW:6472
Bora Pharmaceuticals Co Ltd financials statements
NT$403.00
At close:+11.50 (+2.94%)
Bora Pharmaceuticals Co Ltd (6472) Financial Statements
Bora Pharmaceuticals Co Ltd Financial Overview
Bora Pharmaceuticals Co Ltd's market cap is currently NT$50.12B. The company's EPS TTM is NT$12.26; its P/E ratio is 32.71; and it has a dividend yield of 2.48%. Bora Pharmaceuticals Co Ltd is estimated to report earnings on November 18, 2026, and the estimated EPS forecast is NT$5.23. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 19.01B | NT$ 19.25B | NT$ 14.20B | NT$ 10.49B | NT$ 4.90B |
| Gross Profit | NT$ 7.66B | NT$ 7.71B | NT$ 6.99B | NT$ 2.91B | NT$ 1.67B |
| Operating Income | NT$ 3.29B | NT$ 3.38B | NT$ 5.25B | NT$ 1.95B | NT$ 1.08B |
| EBITDA | NT$ 4.23B | NT$ 6.46B | NT$ 5.86B | NT$ 2.27B | NT$ 1.29B |
| Net Income | NT$ 2.98B | NT$ 3.94B | NT$ 3.03B | NT$ 1.39B | NT$ 749.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 5.14B | NT$ 5.92B | NT$ 3.40B | NT$ 3.53B | NT$ 910.83M |
| Total Assets | NT$ 44.71B | NT$ 45.60B | NT$ 25.05B | NT$ 22.76B | NT$ 7.37B |
| Total Debt | NT$ 18.23B | NT$ 18.98B | NT$ 5.01B | NT$ 7.60B | NT$ 2.23B |
| Net Debt | NT$ 13.11B | NT$ 13.15B | NT$ 1.96B | NT$ 4.32B | NT$ 1.32B |
| Total Liabilities | NT$ 27.24B | NT$ 30.59B | NT$ 13.29B | NT$ 17.62B | NT$ 4.22B |
| Stockholders' Equity | NT$ 15.38B | NT$ 12.87B | NT$ 9.08B | NT$ 4.53B | NT$ 3.15B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 3.31B | NT$ 293.76M | NT$ 3.18B | NT$ 1.81B | NT$ 873.05M |
| Operating Cash Flow | NT$ 4.24B | NT$ 980.81M | NT$ 4.61B | NT$ 2.01B | NT$ 1.24B |
| Investing Cash Flow | NT$ -3.45B | NT$ -10.68B | NT$ -2.46B | NT$ -4.28B | NT$ -225.85M |
| Financing Cash Flow | NT$ -1.04B | NT$ 12.07B | NT$ -2.44B | NT$ 4.59B | NT$ -741.40M |
Currency in TWD
